|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/24 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3328887 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17840546.0 |
| Date of filing the European patent application | 2017-09-18 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/102057 |
| Date | 2017-09-18 |
| (87) | Number | WO 2018/050111 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201610831525 | 2016-09-19 | CN | |
| 201610832677 | 2016-09-19 | CN |
| (72) |
WANG, Zhengyi , CN
FANG, Lei , CN
GUO, Bingshi , CN
ZANG, Jingwu , CN
|
| (73) |
I-Mab Biopharma (Hangzhou) Co., Ltd. ,
6F, No.3 Bld., Hexiang Technology Center, Qiantang New Area
Hangzhou
Zhejiang,
CN
|
| (54) | ANTI-GM-CSF ANTIBODIES AND USES THEREOF |
| ANTI-GM-CSF ANTIBODIES AND USES THEREOF |